Hydroxychloroquine is used to treat malaria. It is also used to prevent malaria infection in areas or regions where it is known that other medicines (eg, chloroquine) may not work. Hydroxychloroquine belongs to a group of medicines known as antimalarials. It works by preventing or treating malaria, a red blood cell infection transmitted by the bite of a mosquito. However, this medicine is not used to treat severe or complicated malaria. Hydroxychloroquine is used to treat discoid lupus erythematosus (DLE) or systemic lupus erythematosus (SLE or lupus). It is also used to treat acute and chronic rheumatoid arthritis.This medicine is available only with your doctor’s prescription. This product is available in the following dosage forms:
TabletMore about Concordia Pharma Marketed Plaquenil
Concordia Manufacturer Information in the USA compared to Sanofi Aventis
Plaquenil (hydroxychloroquine) is prescribed for arthritis and rheumatic disorders, malaria, and a variety of autoimmune disorders such as systemic lupus erythematosus or SLE.
In the USA, Plaquenil is marketed by Concordia Pharmaceuticals Inc. US Plaquenil container labels approved in 2019 state that the product is manufactured for Concordia Pharmaceuticals Inc., located in St Michael, Barbados. The labelling letter on the FDA website states that the product will continue to be manufactured at the currently approved facility. Prior to this, Sanofi Aventis, US, is stated on the label. The FDA site shows no manufacturing changes have been approved since 2002.
Plaquenil is sold by Sanofi-Aventis Canada Inc., in Canada. Similarly, Sanofi-Aventis sells Plaquenil in New Zealand and Australia.
All of the drug descriptions are similar in terms of ingredients and identical in terms of appearances. Some of the ingredient names are different but refer to the same ingredient:
Canada: Medicinal ingredient: hydroxychloroquine sulfate.
Each 200 mg tablet contains 155 mg of hydroxychloroquine as the base. Non-medicinal ingredients: black ink, calcium hydrogenophosphate, carnauba wax, corn starch, magnesium stearate, Opadry White YS-I-7443 and polyethylene glycol 400.
USA: PLAQUENIL (hydroxychloroquine sulfate) tablets for oral administration contain 200 mg hydroxychloroquine sulfate (equivalent to 155 mg of hydroxychloroquine) and the following inactive ingredients: black iron oxide, carnauba wax, corn starch, dibasic calcium phosphate, hydroxypropyl methylcellulose, magnesium stearate, polyethylene glycol 400, polysorbate 80, titanium dioxide
Canada: Plaquenil (hydroxychloroquine sulfate tablets) is available as white to off-white, film coated, peanut-shaped tablets, containing 200mg hydroxychloroquine sulfate (equivalent to 155mg base), with PLAQUENIL printed in black on one side.
USA: Plaquenil tablets contain 200mg of hydroxychloroquine sulfate (equivalent to 155mg base). White to off-white film-coated, no score, tablet imprinted with “PLAQUENIL” on one face in black ink.
For many products we offer a lower per unit cost when you purchase larger quantities. If your quantity is larger than what is available on this website, please contact us directly.
Brand-name and generic products are therapeutically equivalent.
Whatever source country you choose, your product will take about the same number of days to arrive.
Your order for Hydroxychloroquine will be shipped in discreet packaging so whether the item is shipped to your home or work no one will know the contents of the shipment until opened.
Average regular delivery time:
10 days from our Canadian online pharmacy.
Delivery times for Hydroxychloroquine do vary depending on the location of the dispensary. The reason deliveries take time is primarily due to customs procedures that need to be completed prior to allowing our packages to enter the United States. Expedited and tracked delivery services are available from our Canadian online dispensary. Please speak to one of our online pharmacy service representatives if you have any questions about delivery times for your order.